GOLGA8O Activators are a diverse set of chemical compounds that, through various cellular mechanisms, enhance the activity of GOLGA8O, a protein involved in the organization and trafficking of the Golgi apparatus. Forskolin acts by increasing intracellular cAMP, which, through the activation of PKA, potentially enhances the phosphorylation of targets involved with the Golgi, thus supporting GOLGA8O's function. Similarly, PMA, through the activation of PKC, may lead to the phosphorylation of proteins that interact with the Golgi, thereby indirectly boosting the activity of GOLGA8O. Brefeldin A, by inhibiting ARF, disrupts the Golgi structure, which could trigger cellular responses that upregulate GOLGA8O activity to counteract this disruption. Moreover, the use of GTPγS to activate GTPases involved in vesicular trafficking could also augment the role of GOLGA8O in the Golgi apparatus.
Additionally, the application of okadaic acid may result in the hyperphosphorylation of proteins, potentially affecting GOLGA8O's state or the state of proteins in its functional network, thereby enhancing its activity. Nocodazole's impact on microtubule dynamics can influence Golgi positioning and function, which might indirectly elevate GOLGA8O's role in maintaining Golgi structure. Similarly, Monensin's alteration of ion concentrations can lead to changes in Golgi function, which may enhance GOLGA8O activity. Lithium chloride's inhibition of GSK-3 could activate various proteins, potentially leading to the enhancement of GOLGA8O's Golgi-related functions. Proteasome inhibition by MG132 might prevent the degradation of proteins critical to Golgi maintenance, indirectly supporting GOLGA8O's role. Furthermore, EGCG's broad kinase inhibition could modulate signaling pathways to favor GOLGA8O activity, while NAD+ may influence GOLGA8O by affecting cellular energy states and associated signaling. Lastly, Cytochalasin D's interference with actin polymerization can lead to alterations in Golgi structure and function, which may serve to indirectly enhance the activity of GOLGA8O within these cellular processes.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly stimulates adenylate cyclase, increasing cAMP levels in cells. Elevated cAMP activates PKA, which can phosphorylate proteins associated with the Golgi apparatus, potentially enhancing the function of GOLGA8O in Golgi organization and trafficking. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which is known to phosphorylate a wide spectrum of target proteins, including those involved in maintaining the Golgi structure, which could lead to the functional enhancement of GOLGA8O. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A disrupts Golgi structure by inhibiting ADP-ribosylation factor (ARF), which could lead to compensatory mechanisms that enhance GOLGA8O activity to maintain Golgi integrity. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
A potent inhibitor of serine/threonine phosphatases, okadaic acid can lead to hyperphosphorylation of cellular proteins, potentially enhancing GOLGA8O activity by modifying its phosphorylation state or that of associated proteins. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Microtubule depolymerizing agent that could enhance GOLGA8O activity by affecting microtubule dynamics and thus influencing Golgi apparatus positioning and function. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
An ionophore that alters intracellular ion concentrations and pH, which can lead to changes in Golgi apparatus function and potentially enhance the activity of GOLGA8O. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Inhibits GSK-3, which indirectly leads to the activation of various proteins. This alteration in signaling cascades could enhance GOLGA8O function related to the Golgi apparatus. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A proteasome inhibitor that could enhance GOLGA8O activity by preventing the degradation of proteins involved in Golgi maintenance, thereby indirectly supporting GOLGA8O's function. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
A catechin found in green tea that has been shown to inhibit a variety of kinases, potentially modifying signaling pathways that enhance GOLGA8O activity. | ||||||
NAD+, Free Acid | 53-84-9 | sc-208084B sc-208084 sc-208084A sc-208084C sc-208084D sc-208084E sc-208084F | 1 g 5 g 10 g 25 g 100 g 1 kg 5 kg | $57.00 $191.00 $302.00 $450.00 $1800.00 $3570.00 $10710.00 | 4 | |
A coenzyme involved in redox reactions that could indirectly influence GOLGA8O activity by affecting the overall cellular energy state and signaling pathways associated with the maintenance of the Golgi apparatus. | ||||||